Abbott to sell developed markets branded generics business to Mylan
Abbott to get 21 per cent of a newly formed publicly traded company consisting of its developed markets pharma business and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
High prices hinder access to newer HIV drugs: MSF report
For middle-income countries the situation is worse, with some countries paying over 12 times more than the lowest known price
Elder Pharma to make Eldervit, Thrive super brands
Self-owned brands, especially in anti-infectives, lifestyle diseases, dermatology and neurology, to get a major boost
US FDA approves Zydelig for three types of blood cancers
The US Food and Drug Administration has approved Zydelig (idelalisib) to treat patients with three types of blood cancers
Glenmark’s consolidated revenue increases by 20.08 per cent
Consolidated net profit increases by 43.65 per cent
GVK BIO launches brand CLINOGENT
To offer bioequivalence studies for generic pharma and late phase patient-based clinical studies for research-based companies
IPM garners Rs 6636 crores in June
The Mumbai market grew the highest at 24.3 per cent followed by Vidarbha at 21.3 per cent
DIA to organise 9th Annual India Conference
It will be held in Mumbai from October 16-18, 2014; the theme for the event will be ‘The Future of Indian Healthcare: Patients,…
IDMA’s writ petition results in relief for the nutra sector
IDMA briefing on impact of Mumbai HC order quashing FSSAI advisory
IPA sends charter of demands to Health Minister to pharmacists
Include minimum pay equivalent to primary teacher or junior engineer